| Breakdown | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 73.71B | 69.92B | 68.19B | 65.76B | 61.34B |
| Gross Profit | 5.55B | 5.36B | 4.85B | 4.68B | 4.69B |
| EBITDA | 5.01B | 4.23B | 4.83B | 3.19B | 4.39B |
| Net Income | 1.79B | 1.63B | 1.19B | 737.00M | 1.48B |
Balance Sheet | |||||
| Total Assets | 39.47B | 38.89B | 47.04B | 46.13B | 49.35B |
| Cash, Cash Equivalents and Short-Term Investments | 4.16B | 4.63B | 4.67B | 4.45B | 4.65B |
| Total Debt | 15.08B | 14.67B | 14.84B | 15.08B | 15.36B |
| Total Liabilities | 28.02B | 27.23B | 35.37B | 33.90B | 33.71B |
| Stockholders Equity | 11.46B | 11.67B | 11.67B | 12.24B | 15.66B |
Cash Flow | |||||
| Free Cash Flow | 2.80B | 1.68B | 2.45B | 2.56B | 2.61B |
| Operating Cash Flow | 4.14B | 2.92B | 3.84B | 3.81B | 3.79B |
| Investing Cash Flow | -943.00M | -441.00M | -1.70B | -790.00M | -1.77B |
| Financing Cash Flow | -3.09B | -2.94B | -1.86B | -3.19B | -2.23B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £30.48B | 17.50 | 16.05% | 3.25% | 5.43% | 15.99% | |
69 Neutral | £12.77B | 7.89 | 8.44% | 2.98% | -2.16% | -24.87% | |
68 Neutral | £1.67B | 14.01 | 20.47% | 3.34% | 6.79% | -20.45% | |
66 Neutral | £1.76B | 12.40 | 34.04% | 17.38% | 1.74% | -23.72% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | £7.44B | 20.67 | 6.12% | 4.02% | 2.54% | 12.99% | |
52 Neutral | £1.70B | 3.62 | 24.47% | ― | ― | ― |